Psycho-Oncology

REFERENCES

• Holland JC. History of psycho-oncology: overcoming attitudinal and conceptual barriers. Psychosom Med 2002;64:206–21.
   PubMed Web of Science ®Google Scholar
• Holland JH, Friedlander MM. Oncology. In: Blumenfield M, Strain JJ, eds. Psychosomatic medicine. Philadelphia, Ontario: Lippincott Williams & Wilkins, 2006.
   Google Scholar
• Holland JC, Gooen-Piels J. Psycho-oncology. In: Holland JC, Frei E, eds. Cancer medicine. 6th ed. Hamilton, BC Decker, 2003.
   Google Scholar
• Bylund CL, Brown RF, di Ciccone BL, et al. Training faculty to facilitate communication skills training: development and evaluation of a workshop. Patient Educ Couns 2008;70:430–6.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. Clinical practice guidelines in oncology: distress management. Ver. 1. 2010. http://www.nccn.org/professionals/physician_gls/PDF/distress.pdf
   Google Scholar
• Snyder DC, Morey MC, Sloane R, et al. Reach out to ENhancE Wellness in Older Cancer Survivors (RENEW): design, methods and recruitment challenges of a home-based exercise and diet intervention to improve physical function among long-term survivors of breast, prostate, and colorectal cancer. Psychooncology 2009;18:429–39.
   PubMed Web of Science ®Google Scholar
• Breitbart W, Lederberg MS, Rueda-Lara M, Alici Y. Psycho-oncology. In: Sadock BJ, Sadock VA, eds. Kaplan and Sadock's synopsis of psychiatry. 10th ed. Philadelphia: Lippincott Williams & Wilkins, 2009.
   Google Scholar
• Capuron L, Gumnick JF, Musselman DL, et al. Neurobehavioral effects of interferon alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002;26:643–52.
   PubMed Web of Science ®Google Scholar
• Jacobson CM, Rosenfeld B, Pessin H, Breitbart W. Depression and IL-6 blood plasma concentrations in advanced cancer patients. Psychosomatics 2008;49:64–6.
   PubMedGoogle Scholar
• Ahles TA, Saykin AJ, Furstenberg CT, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002;20:485–93.
   PubMed Web of Science ®Google Scholar
• Rao A, Cohen HJ. Symptom management in the elderly cancer patient: fatigue, pain, and depression. J Natl Cancer Inst 2004;32:150–7.
   Google Scholar
• Winell J, Roth AJ. Psychiatric assessment and symptom management in elderly cancer patients. Oncology (Williston Park) 2005;19:1479–90.
   PubMedGoogle Scholar
• Breitbart W, Gibson C, Poppito SR, Berg A. Psychotherapeutic interventions at the end of life: a focus on meaning and spirituality. Can J Psychiatry 2004;49:366–72.
   PubMed Web of Science ®Google Scholar
• Daniels J, Kissane DW. Psychosocial interventions for cancer patients. Curr Opin Oncol 2008;20:367–71.
   PubMed Web of Science ®Google Scholar
• Breitbart W, Rosenfeld B, Gibson C, et al. Meaning-centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial. Psychooncology. 2009 Mar 9 [Epub ahead of print].
   Google Scholar
• Lengacher CA, Johnson-Mallard V, Post-White J, et al. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology. 2009 Feb 20 [Epub ahead of print].
   PubMedGoogle Scholar
• Jacobsen PB. Promoting evidence-based psychosocial care for cancer patients. Psychooncology 2009;18:6–13.
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Morrow GR, Fetting D, et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983;249:751–7.
   PubMed Web of Science ®Google Scholar
• Park C, Folkman S. Meaning in the context of stress and coping. Rev Gen Psychol 1997;1:115–44.
   Google Scholar
• Li J, Johansen C, Hansen D, Olsen J. Cancer incidence in parents who lost a child: a nationwide study in Denmark. Cancer 2002;95:2237–42.
   PubMed Web of Science ®Google Scholar
• Petticrew M, Bell R, Hunter D. Influence of psychological coping on survival and recurrence in people with cancer: systematic review BMJ 2002;325:1066–75.
   PubMed Web of Science ®Google Scholar
• Schapiro IR, Nielsen LF, Jørgensen T, Boesen EH, Johansen C. Psychic vulnerability and the associated risk for cancer. Cancer 2002;94:3299–306.
   PubMedGoogle Scholar
• Hansen PE, Floderus B, Frederiksen K, Johansen C. Personality traits, health behavior, and risk for cancer: a prospective study of Swedish twin court. Cancer 2005;103:1082–91.
   PubMedGoogle Scholar
• Bergelt C, Christensen J, Prescott E, Grønbaek M, Koch U, Johansen C. Vital exhaustion and risk for cancer: a prospective cohort study on the association between depressive feelings, fatigue, and risk of cancer. Cancer 2005;104:1288–95.
   PubMedGoogle Scholar
• Dalton SO, Boesen EH, Ross L, Schapiro IR, Johansen C. Mind and cancer: do psychological factors cause cancer? Eur J Cancer 2002;38:1313–23.
   PubMed Web of Science ®Google Scholar
• Rowland JH. Interpersonal resources: developmental stage of adaptation: adult model. In: Holland JC, Rowland JH, eds. Handbook of psycho-oncology: psychological care of the patient with cancer. New York: Oxford University Press, 1989.
   Google Scholar
• Marmot M. Social determinants of health inequalities. Lancet 2005;365:1099–104.
   PubMed Web of Science ®Google Scholar
• Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004;32:57–71.
   PubMedGoogle Scholar
• Chochinov HM, Wilson KG, Enns M, Lander S. Prevalence of depression in the terminally ill: effects of diagnostic criteria and symptom threshold judgments. Am J Psychiatry 1994;151:537–40.
   PubMed Web of Science ®Google Scholar
• Casarett DJ, Inouye SK. Diagnosis and management of delirium near the end of life. Ann Intern Med 2001;135:32–40.
   PubMed Web of Science ®Google Scholar
• Breitbart W, Alici Y. Agitation and delirium at the end of life: “We couldn't manage him.” JAMA 2008;300:2898–910.
   PubMed Web of Science ®Google Scholar
• Holland JC, Andersen B, Breitbart WS, et al. Distress management. J Natl Compr Canc Netw 2007;5:66–98.
   PubMedGoogle Scholar
• Adler NE, Page NEK, eds. Cancer care for the whole patient: meeting psychosocial health needs. Washington, DC: National Academies, 2008.
   Google Scholar
• Moorey S, Greer S, Watson M, et al. Adjuvant psychological therapy for patients with cancer: outcome at one year. Psychooncology 1994;3:39–46.
   Google Scholar
• Gielissen MF, Verhagen CA, Bleijenberg G. Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer 2007;97:612–8.
   PubMed Web of Science ®Google Scholar
• Kissane DW, Grabsch B, Clarke DM, et al. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology 2007;16:277–86.
   PubMed Web of Science ®Google Scholar
• Kissane DW, Bloch S, Smith GC, Miach P, et al. Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial. Psycho-Oncology 2003;12:532–46.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: American Psychiatric Press, 2000.
   Google Scholar
• Caraceni A, Nanni O, Maltoni M, et al. Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer 2000;89:1145–9.
   PubMed Web of Science ®Google Scholar
• Maltoni M, Caraceni A, Brunelli C, et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations—a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 2005;23:6240–8.
   PubMed Web of Science ®Google Scholar
• Trzepacz PT, Breitbart W, Franklin J, et al. Practice guideline for the treatment of patients with delirium. American Psychiatric Association. Am J Psychiatry 1999;156(5 suppl):1–20.
   Google Scholar
• Breitbart W, Gibson C, Tremblay A. The delirium experience: delirium recall and delirium related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002;43:183–94.
   PubMed Web of Science ®Google Scholar
• Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000;160:786–94.
   PubMed Web of Science ®Google Scholar
• Ljubisavljevic V, Kelly B. Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry 2003;25:345–52.
   PubMed Web of Science ®Google Scholar
• Morita T, Tei Y, Tsunoda J, Inoue S, Chihara S, et al. Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage 2001;22:997–1006.
   PubMed Web of Science ®Google Scholar
• Breitbart W, Friedlander M. Confusion/delirium. In: Bruera E, Higginson I, Ripamonti C, von Gunten C, eds. Palliative medicine. London: London Hodder, 2006.
   Google Scholar
• Gaudreau JD, Gagnon P, Harel F, Roy MA, Tremblay A. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005;23:6712–8.
   PubMed Web of Science ®Google Scholar
• Stagno D, Gibson C, Breitbart W. The delirium subtypes: a review of prevalence, phenomenology, pathophysiology, and treatment response. Palliat Support Care 2004;2:171–9.
   PubMedGoogle Scholar
• Spiller JA, Keen JC. Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care. Palliat Med 2006;20:17–23.
   PubMed Web of Science ®Google Scholar
• Breitbart W, Marotta R, Platt MM, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153:231–7.
   PubMed Web of Science ®Google Scholar
• Kiely DK, Jones RN, Bergmann MA, Marcantonio ER. Association between psychomotor activity delirium subtypes and mortality among newly admitted postacute facility patients. J Gerontol A Biol Sci Med Sci 2007;62:174–9.
   PubMed Web of Science ®Google Scholar
• Smith M, Breitbart W, Platt M. A critique of instruments and methods to detect, diagnose, and rate delirium. J Pain Symptom Manage 1994;10:35–77.
   Google Scholar
• Trzepacz PT: The Delirium Rating Scale: its use in consultation-liaison research. Psychosomatics 1999;40:193–204.
   PubMed Web of Science ®Google Scholar
• Breitbart W, Rosenfeld B, Roth A. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997;13:128–37.
   PubMed Web of Science ®Google Scholar
• Lawlor P, Nekolaichuck C, Gagnon B, Mancini I, Pereira J, Bruera E. Clinical utility, factor analysis and further validation of the Memorial Delirium Assessment Scale (MDAS). Cancer 2000;88:2859–67.
   PubMed Web of Science ®Google Scholar
• Inouye SK, Vandyck C, Alessi C. Clarifying confusion: the confusion assessment method, a new method for the detection of delirium. Ann Intern Med 1990;113:941–8.
   PubMed Web of Science ®Google Scholar
• Ryan K, Leonard M, Guerin S, Donnelly S, Conroy M, Meagher D. Validation of the confusion assessment method in the palliative care setting. Palliat Med 2009;23:40–5.
   PubMedGoogle Scholar
• Pitkala KH, Laurila JV, Strandberg TE, Kautiainen H, Sintonen H, Tilvis RS. Multicomponent geriatric intervention for elderly inpatients with delirium: effects on costs and health-related quality of life. J Gerontol A Biol Sci Med Sci 2008;63:56–61.
   PubMed Web of Science ®Google Scholar
• Milisen K, Lemiengre J, Braes T, Foreman MD. Multicomponent intervention strategies for managing delirium in hospitalized older people: systematic review. J Adv Nurs 2005;52:79–90.
   PubMed Web of Science ®Google Scholar
• Boettger S, Breitbart W. Atypical antipsychotics in the management of delirium: a review of the empirical literature. Palliat Support Care 2005;3:227–37.
   PubMedGoogle Scholar
• Seitz DP, Gill SS, van Zyl LT. Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry 2007;68:11–21.
   PubMed Web of Science ®Google Scholar
• Lonergan E, Britton AM, Luxenberg J, Wyller T. Antipsychotics for delirium. Cochrane Database Syst Rev 2007;(2):CD005594.
   PubMedGoogle Scholar
• Jackson KC, Lipman AG. Drug therapy for delirium in terminally ill patients. Cochrane Database Syst Rev 2004;(2):CD004770.
   Google Scholar
• U.S. Food and Drug Administration. Information on antipsychotics. 2009. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107211.htm
   Google Scholar
• Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005;353:2335–41.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Information for healthcare professionals: haloperidol (marketed as haldol, haldol decanoate and haldol lactate). 2009. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm085203.htm
   Google Scholar
• Lawlor PG, Fainsinger RL, Bruera ED. Delirium at the end of life: critical issues in clinical practice and research. JAMA 2000;284:2427–9.
   PubMed Web of Science ®Google Scholar
• Gagnon B, Low G, Schreier G. Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. J Psychiatry Neurosci 2005;30:100–7.
   PubMed Web of Science ®Google Scholar
• Keen JC, Brown D. Psychostimulants and delirium in patients receiving palliative care. Palliat Support Care 2004;2:199–202.
   PubMedGoogle Scholar
• Morita T, Otani H, Tsunoda J, Inoue S, Chihara S. Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate. Support Care Cancer 2000;8:134–7.
   PubMed Web of Science ®Google Scholar
• Roy-Byrne PP, Davidson KW, Kessler RC, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008;30:208–25.
   PubMed Web of Science ®Google Scholar
• Strain J. Adjustment disorders. In: Holland JC, ed. Psycho-oncology. New York: Oxford University Press, 1998.
   Google Scholar
• Hay JL, McCaul KD, Magnan RE. Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence. Prev Med 2006;42:401–8.
   PubMed Web of Science ®Google Scholar
• Rasic DT, Belik S-L, Bolton JM, Chochinov HM, Sareen J. Cancer, mental disorders, suicidal ideation and attempts in a large community sample. Psychooncology 2008;17:660–7.
   PubMed Web of Science ®Google Scholar
• Kangas M, Henry JL, Bryant RA. Correlates of acute stress disorder in cancer patients. J Trauma Stress 2007;20:325–34.
   PubMed Web of Science ®Google Scholar
• Palmer SC, Kagee A, Coyne JC, DeMichelle A. Experience of trauma, distress, and posttraumatic stress disorder among breast cancer patients. Psychosom Med 2004;66:258–64.
   PubMed Web of Science ®Google Scholar
• Kroll J. Posttraumatic symptoms and the complexity of responses to trauma. JAMA 2003;290:267–70.
   Google Scholar
• Jacobsen PB, Redd WH. The development and management of chemotherapy-related anticipatory nausea and vomiting. Cancer Invest 1988;6:329–36.
   PubMed Web of Science ®Google Scholar
• Noyes R, Holt CS, Massie MJ. Anxiety disorders. In: Holland JC, Breitbart W, eds. Psycho-oncology. New York: Oxford University Press, 1998.
   Google Scholar
• Teunissen SC, de Graeff A, Voest EE, de Haes JC. Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patients. Palliat Med 2007;21:341–6.
   PubMedGoogle Scholar
• Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol 2002;20:3137–48.
   PubMed Web of Science ®Google Scholar
• Jackson KC, Lipman AG. Drug therapy for anxiety in palliative care. Cochrane Database Syst Rev 2004;(1):CD004596.
   Google Scholar
• Coups EJ, Winell J, Holland JC. Depression in the context of cancer. In: Licinio J, Wong M-L, eds. Biology of depression: from novel insights to therapeutic strategies, vol. 1. Weinheim, Germany: Wiley, 2005.
   Google Scholar
• Ebrahimi B, Tucker SL, Li D, Abruzzese JL, Kurzrock R. Cytokines in pancreatic carcinoma. Cancer 2004;101:2727–36.
   PubMed Web of Science ®Google Scholar
• Laird BJ, Boyd AC, Colvin LA, Fallon MT. Are cancer pain and depression interdependent? A systematic review. Psychooncology 2009;18:459–64.
   PubMedGoogle Scholar
• Musselman DL, Miller AH, Porter MR, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001;158:1252–7.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Practice guidelines for the treatment of patients with major depressive disorder. 2nd ed. Arlington, VA: American Psychiatric Publishing, 2000.
   Google Scholar
• Hemaryeck A, Belpaire FM. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Curr Drug Metab 2002;3:13–37.
   PubMedGoogle Scholar
• Henry NL, Stearns V, Flockhart DA, Hayes DF, Riba M. Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. Am J Psychiatry 2008;165:1251–5.
   PubMed Web of Science ®Google Scholar
• Breitbart W. Suicide risk and pain in cancer and AIDS patients. In: Chapman CR, Foley KM, eds. Current and emerging issues in cancer pain: research and practice. New York: Raven, 1993.
   Google Scholar
• Kendal WS. Suicide and cancer: a gender-comparative study. Ann Oncol 2007;18:381–7.
   PubMed Web of Science ®Google Scholar
• Chochinov HM, Wilson KG, Ennis M, Lander S. Depression, hopelessness, and suicidal ideation in the terminally ill. Psychosomatics 1998;39:336–70.
   Google Scholar
• Lin HC, Wu CH, Lee HC. Risk factors for suicide following hospital discharge among cancer patients. Psychooncology 2009;18:1038–44.
   PubMed Web of Science ®Google Scholar
• Labisi O. Assessing for suicide risk in depressed geriatric cancer patients. J Psychosoc Oncol 2006;24:43–50.
   PubMed Web of Science ®Google Scholar
• Schairer C, Brown LM, Chen BE, et al. Suicide after breast cancer: an international population-based study of 723,810 women. J Natl Cancer Inst 2006;98:1416–9.
   PubMed Web of Science ®Google Scholar
• Mock V, Atkinson A, Barsevick A, et al. NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park) 2000;14:151–61.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. Clinical practice guidelines in oncology: cancer-related fatigue. Ver. 1. 2009. http://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf
   Google Scholar
• Mystakidou K, Parpa E, Katsouda E, Galanos A, Vlahos L. The role of physical and psychological symptoms in desire for death: a study of terminally ill cancer patients. Psychooncology 2006;15:355–60.
   PubMed Web of Science ®Google Scholar
• Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the scale of the problem. Oncologist 2007;12 suppl 1:4–10.
   PubMed Web of Science ®Google Scholar
• Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 2004;(32):40–50.
   PubMedGoogle Scholar
• Ahlberg KT, Ekman, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet 2003;362:640–50.
   Google Scholar
• Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W. Progress toward guidelines for the management of fatigue. Oncology (Williston Park) 1998;12:369–77.
   PubMed Web of Science ®Google Scholar
• Sadler IJ, Jacobsen PB, Booth-Jones M, Belanger H, Weitzner MA, Fields KK. Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. J Pain Symptom Manage 2003;23:406–16.
   Google Scholar
• Mock V. Evidence-based treatment for cancer-related fatigue. J Natl Cancer Inst Monogr 2004;(32):112–8.
   PubMedGoogle Scholar
• Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K. Management of cancer related fatigue. Cancer Invest 2005;23:229–39.
   PubMed Web of Science ®Google Scholar
• Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 2001;161:411–20.
   PubMedGoogle Scholar
• Bruera EL, Driver L, Barnes EA. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 2003;21:4439–43.
   PubMed Web of Science ®Google Scholar
• Bruera E, Valero V, Driver L, et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 2006;24:2073–8.
   PubMed Web of Science ®Google Scholar
• Cullum JL, Wojciechowski AE, Pelletier G, Simpson JS. Bupropion sustained release treatment reduces fatigue in cancer patients. Can J Psychiatry 2004;49:139–44.
   PubMed Web of Science ®Google Scholar
• Morrow GR, Hickok JT, Roscoe JA, et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 2003;21:4635–41.
   PubMed Web of Science ®Google Scholar
• Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001;344:961–6.
   PubMed Web of Science ®Google Scholar
• Roscoe JA, Morrow GR, Hickok JT, et al. Effect of paroxetine hydrochloride on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 2005;89:243–9.
   PubMed Web of Science ®Google Scholar
• Hurria A, Somlo G, Ahles T. Renaming “chemobrain.” 2007;25:373–7.
   Google Scholar
• Nelson CJ, Nandy N, Roth AJ. Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliat Support Care 2007;5:273–80.
   PubMedGoogle Scholar
• Ahles TA, Saykin AJ, Noll WW, et al. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard-dose chemotherapy. Psychooncology 2003;12:612–9.
   PubMed Web of Science ®Google Scholar
• Baider L, Cooper CL, De-Nour AK, eds. Cancer and the family. 2nd ed. Chichester, England: Wiley & Sons, 2000.
   Google Scholar
• Ostlund U, Wennman-Larsen A, Persson C, Gustavsson P, Wengström Y. Mental health in significant others of patients dying from lung cancer. Psychooncology. 2009 Feb 27 [Epub ahead of print].
   Google Scholar
• Kissane D, Lichtenthal WG, Zaider T. Family care before and after bereavement. Omega (Westport) 2007–2008;56:21–32.
   PubMed Web of Science ®Google Scholar